143 related articles for article (PubMed ID: 18214444)
1. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Arch Toxicol; 2008 Sep; 82(9):607-14. PubMed ID: 18214444
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
3. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
Obatomi DK; Bach PH
In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
[TBL] [Abstract][Full Text] [Related]
4. Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity.
Benesic A; Schwerdt G; Mildenberger S; Freudinger R; Gordjani N; Gekle M
Kidney Int; 2005 Nov; 68(5):2029-41. PubMed ID: 16221203
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
Chen N; Aleksa K; Woodland C; Rieder M; Koren G
Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
Brüggemann SK; Kisro J; Wagner T
Cancer Res; 1997 Jul; 57(13):2676-80. PubMed ID: 9205076
[TBL] [Abstract][Full Text] [Related]
9. Targets of chloroacetaldehyde-induced nephrotoxicity.
Knouzy B; Dubourg L; Baverel G; Michoudet C
Toxicol In Vitro; 2010 Feb; 24(1):99-107. PubMed ID: 19733226
[TBL] [Abstract][Full Text] [Related]
10. Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.
Benesic A; Schwerdt G; Freudinger R; Mildenberger S; Groezinger F; Wollny B; Kirchhoff A; Gekle M
Kidney Blood Press Res; 2006; 29(5):280-93. PubMed ID: 17035713
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide and mesna: effects on the Na/H exchanger activity in renal epithelial cells in culture (LLC-PK1).
Mohrmann M; Küpper N; Schönfield B; Brandis M
Ren Physiol Biochem; 1995; 18(3):118-27. PubMed ID: 7542792
[TBL] [Abstract][Full Text] [Related]
13. Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.
MacAllister SL; Martin-Brisac N; Lau V; Yang K; O'Brien PJ
Chem Biol Interact; 2013 Feb; 202(1-3):259-66. PubMed ID: 23220588
[TBL] [Abstract][Full Text] [Related]
14. A tubule cell model for ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular transport and nephrotoxicity of DDA.
Koschier FJ; Stokols MF; Cattrall PJ; Conway WD; Acara M; Hong SK
J Environ Pathol Toxicol; 1980; 3(5-6):513-27. PubMed ID: 6255051
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-induced nephrotoxicity: mechanism and prevention.
Nissim I; Horyn O; Daikhin Y; Nissim I; Luhovyy B; Phillips PC; Yudkoff M
Cancer Res; 2006 Aug; 66(15):7824-31. PubMed ID: 16885387
[TBL] [Abstract][Full Text] [Related]
17. The nephrotoxic Ifosfamide-metabolite chloroacetaldehyde interferes with renal extracellular matrix homeostasis.
Benesic A; Schwerdt G; Hennemeier I; Sauvant C; Mildenberger S; Gekle M
Cell Physiol Biochem; 2014; 33(4):1106-16. PubMed ID: 24732969
[TBL] [Abstract][Full Text] [Related]
18. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
[TBL] [Abstract][Full Text] [Related]
19. An improved approach for determination of Na(+)-K(+)-ATPase activity in single proximal renal tubule of rat.
Gao Y; Luo L; Liu H
Sheng Li Xue Bao; 2007 Jun; 59(3):382-6. PubMed ID: 17579797
[TBL] [Abstract][Full Text] [Related]
20. Necrotic pathway in human osteosarcoma Saos-2 cell death induced by chloroacetaldehyde.
Takahashi K; Sakurai K; Takahashi K; Tanaka H; Fujimoto Y
Anticancer Drugs; 2007 Jun; 18(5):543-53. PubMed ID: 17414623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
